Target intelligence / Profile preview

Bacterial cytoplasmic membrane (Gram-negative) (CM)

Target
CM
Molecular classification
Phospholipid bilayer, Cell membrane
01

Overview

The bacterial cytoplasmic membrane of Gram-negative bacteria, also known as the inner membrane, is a vital phospholipid bilayer that serves as the primary permeability barrier for the cell [1]. It is composed of a variety of lipids, including phosphatidylethanolamine and phosphatidylglycerol, which provide the structural matrix for essential membrane proteins [2]. This membrane is the site of critical biological processes such as oxidative phosphorylation, nutrient transport, and the synthesis of cell wall components [3]. As a therapeutic target, it is primarily exploited by polymyxin antibiotics, which disrupt the bilayer's integrity through electrostatic interactions and lipid displacement [4]. This disruption leads to the loss of the proton motive force and the leakage of cytoplasmic contents, resulting in rapid bacterial death [2]. Despite its effectiveness as a target, the similarity between bacterial and mammalian membranes can lead to significant safety concerns, including nephrotoxicity and neurotoxicity in patients [3]. The membrane also plays a role in signal transduction and the coordination of cell division [1]. Understanding the specific lipid composition of this membrane is crucial for developing new antimicrobial agents that can bypass resistance mechanisms [4].

Other names
Inner membranePlasma membraneCytoplasmic membraneBacterial inner membrane
02

Mechanism of action

Disruption of the phospholipid bilayer through electrostatic binding and displacement of divalent cations, leading to pore formation, membrane depolarization, and leakage of intracellular contents.

03

Biological functions

Selective permeabilityEnergy productionActive transportLipid biosynthesisProtein secretion
04

Disease associations

InfectionSepsisPneumoniaUrinary tract infection
05

Safety considerations

NephrotoxicityNeurotoxicityElectrolyte imbalancesLimited therapeutic index
06

Interacting drugs

Polymyxin B

1 more in the full profile.

07

Biomarkers

Serum creatinineBlood urea nitrogenProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Bacterial cytoplasmic membrane (Gram-negative) (CM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cytoplasmic membrane (Gram-negative) (CM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call